Patent & Trade Mark
Attorneys
We are
Experts in Navigating IP in the Asia Pacific Region
Thanks to many years of global experience, FB Rice has a network of trusted advisors in most key jurisdictions. We turn to those advisors when assisting our clients to promote their interests.

For specific information on our Asia Pacific capability, click here.

 

 
One door to South East Asia
For a seamless service for filing and prosecuting patent and trade mark applications in South East Asia, click here.

 

Patrick McManamny
"The pharmaceutical patent landscape is complex and constantly evolving. At FB Rice, we work with our clients to ensure they are aware of these changes and their effect on their business and goals, whether this is obtaining patent rights or being aware of, or avoiding, third party rights."
"The pharmaceutical patent landscape is complex and constantly evolving. At FB Rice, we work with our clients to ensure they are aware of these changes and their effect on their business and goals, whether this is obtaining patent rights or being aware of, or avoiding, third party rights."
Tobacco on the back foot?
With Europe’s tobacco-products legislation moving forward, Lisa Neilson reviews the lessons learned from Australia’s earlier action.
With Europe’s tobacco-products legislation moving forward, Lisa Neilson reviews the lessons learned from Australia’s earlier action.
13 September 2016
Emerging Polymer Technologies Summit 2016
John Landells, Andrew Gregory, Marianne Repacholi and David Herman are all looking forward to attending the Emerging Polymer Technologies Summit this week.
John Landells, Andrew Gregory, Marianne Repacholi and David Herman are all looking forward to attending the Emerging Polymer Technologies Summit this week.
Mark Teoh

Associate

Mark Teoh

Mark is an Associate in our Sydney Medical Technology with a range of experience across all areas of mechanical engineering with a particular focus on medical technology and mechatronic systems, including medical imaging, implantable bionics, ophthalmic treatments and devices, surgical devices, medical devices, humanoids, prosthetics, diagnostic devices and industrial robotics. 

Mark is a registered Australian Patent and Trade Mark Attorney and a registered New Zealand Patent Attorney.

Mark is an Associate in our Sydney Medical Technology with a range of experience across all areas of mechanical engineering with a particular focus on medical technology and mechatronic systems, including medical imaging, implantable bionics, ophthalmic treatments and devices, surgical devices, medical devices, humanoids, prosthetics, diagnostic devices and industrial robotics. 

Mark is a registered Australian Patent and Trade Mark Attorney and a registered New Zealand Patent Attorney.

23 August 2016
Do you undertake Research and Development activities overseas?
In certain circumstances, R&D activities conducted overseas may qualify to claim the R&D tax offset at the same rate as a company’s Australian based R&D however overseas activities are subject to additional criteria and the issue of the ‘Overseas Finding’.
In certain circumstances, R&D activities conducted overseas may qualify to claim the R&D tax offset at the same rate as a company’s Australian based R&D however overseas activities are subject to additional criteria and the issue of the ‘Overseas Finding’.
Australian High Court approves the Full Federal Court RPL Central decision and rejects appeal
Now that the RPL Central decision has been endorsed by the High Court, we expect IP Australia to refer to this decision more often during examination of computer implemented inventions. In particular, we expect IP Australia to raise patentable subject matter objections to claimed inventions where the substance of the invention is in the idea or business method, rather than in a new and useful effect in a computer.
Now that the RPL Central decision has been endorsed by the High Court, we expect IP Australia to refer to this decision more often during examination of computer implemented inventions. In particular, we expect IP Australia to raise patentable subject matter objections to claimed inventions where the substance of the invention is in the idea or business method, rather than in a new and useful effect in a computer.